The Recall Desk

State

Rhode Island product recalls

20,083 recalls have nationwide distribution and so reach Rhode Island. 0 additional recalls listed Rhode Island specifically in their distribution scope.

About recalls in Rhode Island

Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Rhode Island consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.

If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.

6376–6400 of 20083

  • HighFDA (Devices)·Z-0816-2025·2025-01-15

    Tec 820 SEV Anesthesia Vaporizer Recalled for Inadequate Anesthetic Delivery

    GE Medical Systems is recalling approximately 928 Tec 820 SEV anesthesia vaporizers due to a manufacturing defect that can cause them to deliver less anesthetic agent than the dial setting indicates. The devices are distributed nationwide and globally.

    Product
    Tec 820 SEV Anesthesia Vaporizer, Reference Number 1177-9820-SEV
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0802-2025·2025-01-15

    VACUETTE SAFELINK Blood Collection Holder May Leak Due to Defective Sleeve

    Greiner Bio-One GmbH is recalling VACUETTE SAFELINK blood collection holders because the protective rubber sleeve may bunch up and fail to retract, causing potential blood leakage from the device.

    Product
    VACUETTE SAFELINK, REF: 450210
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0188-2025·2025-01-15

    Duloxetine Delayed-Release Capsules recalled for manufacturing deviation and impurity

    Rising Pharma is recalling certain batches of Duloxetine Delayed-Release Capsules 30 mg due to a manufacturing deviation that resulted in elevated N-nitroso-duloxetine impurity above FDA's recommended interim limit.

    Product
    Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0804-2025·2025-01-15

    Smaxel Fractional CO2 Laser recalled for missing safety label and instructions

    IDS LTD is recalling 23 Smaxel Fractional CO2 Laser systems worldwide due to missing Certification label and inadequate instructions for safe operation.

    Product
    Smaxel Fractional CO2 Laser, a Class IV medical laser system.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0817-2025·2025-01-15

    GE Tec Anesthesia Vaporizers Recalled for Insufficient Anesthetic Delivery

    Certain GE Tec anesthesia vaporizers (Tec 6 Plus and Tec 800 series) may deliver less anesthetic agent than the dial indicates due to a manufacturing issue. Users should cease use and contact GE Medical for instructions.

    Product
    Tec 850 ISO Anesthesia Vaporizer, Reference Number 1177-9850-ISO
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0190-2025·2025-01-15

    Duloxetine Drug Recall Due to Manufacturing Impurity Levels

    Rising Pharma recalls Duloxetine DR Capsules 60 mg nationwide due to N-nitroso-duloxetine impurity levels exceeding FDA limits. Affected batches were distributed nationwide; check lot numbers on bottle labels for affected product.

    Product
    Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0182-2025·2025-01-15

    Ciprofloxacin Ophthalmic Eye Drops Recalled Due to Defective Container

    FDC Limited is recalling 136,181 bottles of Ciprofloxacin Ophthalmic Solution due to defective packaging where the cap spike is lodged in the bottle nozzle, preventing product dispensing.

    Product
    CIPROFLOXACIN — CIPROFLOXACIN (CIPROFLOXACIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0184-2025·2025-01-15

    Clobazam Tablets Recalled for Foreign Tablet Contamination

    Amerisource Health Services LLC is recalling Clobazam 10 mg tablets due to the presence of foreign tablets or capsules in some packages. The recall affects 5,178 cartons with Lot #1019594 distributed nationwide.

    Product
    CLOBAZAM — CLOBAZAM (CLOBAZAM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0185-2025·2025-01-15

    Medroxyprogesterone Acetate Injectable Suspension Recalled for Manufacturing Deviations

    Eugia US LLC is recalling medroxyprogesterone acetate injectable suspension (150mg/mL) due to manufacturing practice deviations. This voluntary recall affects 19,872 vials distributed nationwide.

    Product
    MEDROXYPROGESTERONE ACETATE — MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0189-2025·2025-01-15

    Duloxetine Delayed-Release Capsules Recalled for Manufacturing Impurity Above Safe Limits

    Rising Pharma is recalling 73,680 bottles of Duloxetine 20 mg capsules nationwide due to N-nitroso-duloxetine impurity above recommended limits from manufacturing deviations. No illnesses have been reported.

    Product
    Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0186-2025·2025-01-15

    Progesterone Injection Recalled Nationwide for Glass Particulate Matter

    Eugia US LLC is recalling Progesterone Injection due to a market complaint of glass particles found in vials. The affected batch poses a potential risk to patients who receive injections from contaminated vials.

    Product
    PROGESTERONE — PROGESTERONE (PROGESTERONE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0803-2025·2025-01-15

    Beckman Coulter PTH Assay Reagent Packs Recalled for Filling Defects

    Beckman Coulter is recalling Access PTH assay reagent packs from lot 339071 due to under- or over-filling in well 0, which could cause sealing issues, contamination, and inaccurate test results.

    Product
    Access Intact PTH assay, a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of intact parathyroid hormone (parathyrin, PTH) levels in human serum and plasma using the Access Immunoassay Systems, Catalog Number A16972
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0818-2025·2025-01-15

    Tec 850 SEV Anesthesia Vaporizers Recalled for Insufficient Anesthetic Delivery

    GE Medical Systems recalls Tec 850 SEV anesthesia vaporizers due to a manufacturing defect that may cause them to deliver less anesthetic agent than the dial setting indicates. Affected devices distributed nationwide and globally.

    Product
    Tec 850 SEV Anesthesia Vaporizer, Reference Number 1177-9850-SEV
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0187-2025·2025-01-15

    Colchicine Capsules Recalled Due to Failed Dissolution Specifications

    Granules Pharmaceuticals is recalling Colchicine 0.6 mg capsules nationwide due to failed dissolution specifications detected during stability testing. Patients should contact their healthcare provider for guidance.

    Product
    COLCHICINE — COLCHICINE (COLCHICINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0183-2025·2025-01-15

    Methadone Hydrochloride Tablets recalled for illegible product identification

    West-Ward Columbus is recalling Methadone Hydrochloride Tablets, 5mg, in unit-dose packaging due to illegible product identification on individual tablets. Lot AC2556A was distributed nationwide.

    Product
    METHADONE HYDROCHLORIDE — METHADONE HYDROCHLORIDE (METHADONE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereNHTSA·25V828000·2025-01-12

    Ford Recalls 2025 Maverick for Cylinder Head Manufacturing Defect

    Ford is recalling 2025 Maverick vehicles with defectively manufactured cylinder heads that can leak oil. The leak increases the risk of fire and engine failure.

    Product
    FORD — 2025 FORD MAVERICK
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • HighNHTSA·25V826000·2025-01-12

    2025-2026 RAM Pickup Trucks: Blank Instrument Panel Display Software Error

    Chrysler is recalling 2025-2026 RAM pickup trucks (1500, 2500, 3500, 4500, 5500) because a software error causes the instrument panel display to go blank, preventing drivers from seeing critical warning lights and gear selection.

    Product
    RAM — 2025 RAM 1500
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • HighNHTSA·24V930000·2025-01-12

    2019-2022 Mercedes-Benz Sprinter instrument cluster may be too bright

    Daimler Vans USA is recalling 2019-2022 Mercedes-Benz Sprinter vehicles. The instrument cluster illumination may be too bright and non-adjustable, making it difficult for drivers to see critical safety information and increasing crash risk.

    Product
    MERCEDES-BENZ — 2021 MERCEDES-BENZ SPRINTER 1500
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • HighNHTSA·25V823000·2025-01-12

    2025 Ford Expedition and Other Models Recalled for Brake Booster Malfunction

    Ford is recalling 679 2025 Expedition, Ranger, F-150, Bronco, and Navigator vehicles due to a potential Electronic Brake Booster malfunction that can cause loss of power brake assist, increasing crash risk.

    Product
    FORD — 2025 FORD EXPEDITION
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • HighNHTSA·25V831000·2025-01-12

    2025 Lincoln Navigator Rear Lightbar Cracks May Disable Reverse Lights

    Ford is recalling certain 2025 Lincoln Navigator vehicles. The rear lightbar may develop cracks allowing moisture accumulation, potentially disabling reverse lights and reducing visibility when backing up.

    Product
    LINCOLN — 2025 LINCOLN NAVIGATOR
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • HighNHTSA·25V829000·2025-01-12

    2025 Ford Escape liftgate hinge covers may detach, creating crash risk

    Ford is recalling certain 2025 Escape vehicles because liftgate hinge covers may not be properly secured and can detach. Detached covers can create a distraction or road hazard, increasing crash risk.

    Product
    FORD — 2025 FORD ESCAPE
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereNHTSA·25V656000·2025-01-10

    2025 Toyota Tacoma Driveshaft Defect Risks Steering Failure and Rollaway

    Toyota is recalling certain 2025 Tacoma and Tacoma Hybrid vehicles because the front driveshaft CV joint may deform and break, impairing steering and risking vehicle rollaway while parked.

    Product
    TOYOTA — 2025 TOYOTA TACOMA HYBRID
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • HighNHTSA·25V657000·2025-01-10

    Toyota Tundra and Sequoia Hybrid rear visibility software defect recall

    Toyota is recalling 2022-2025 Tundra, Tundra Hybrid, and 2023-2025 Sequoia Hybrid vehicles due to a software error that may prevent the rearview image from displaying when in reverse, reducing driver visibility and increasing crash risk.

    Product
    TOYOTA — 2023 TOYOTA TUNDRA
    Category
    Vehicle
    Distribution
    Distributed nationwide